Iterum Therapeutics plc (ITRMF) › Net IncomeIterum Therapeutics plc (ITRMF) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$13.46M2017: -$29.41M2018: -$77.06M2019: -$103.13M2020: -$52.01M2021: -$91.56M2022: -$44.43M2023: -$38.37M2024: -$24.77M-$24.77M2016Net Income (USD)2024Fiscal YearNet IncomeChange YoY2024-$24.77M+35.4%2023-$38.37M+13.6%2022-$44.43M+51.5%2021-$91.56M-76.1%2020-$52.01M+49.6%2019-$103.13M-33.8%2018-$77.06M-162.0%2017-$29.41M-118.4%2016-$13.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share